SFM
AUGX

Soros Fund Management’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Soros Fund Management’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-88,516
Closed -$518K – 267
2023
Q4 		$518K Buy
+88,516
New +$466K 0.01% 202

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Soros Fund Management's AUGX Position: Q1 2024 in Review

Soros Fund Management sold out of Augmedix, Inc. Common Stock (AUGX) in Q1 2024, closing a stake of 88,516 shares — an estimated $518K sold.

Soros Fund Management first reported a position in AUGX in Q4 2023 and held it in 1 quarter. The position peaked at $518K in Q4 2023. 84 funds tracked by Wall St. Rank hold AUGX as of Q1 2024.

  • Soros Fund Management reported no remaining Augmedix, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Soros Fund Management sold 88,516 Augmedix, Inc. Common Stock shares in Q1 2024, an estimated $518K.
  • Soros Fund Management first reported a position in Augmedix, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Soros Fund Management's Augmedix, Inc. Common Stock position peaked at $518K in Q4 2023.
  • 84 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q1 2024.

Based on Soros Fund Management's 13F filing for Q1 2024, filed 15 May 2024.